Pulling SEC filings + quote and writing the call…
Core Scientific, Inc./tx
Last earnings -40.7% on 2026-05-06
Conservative balance sheet (liabilities/equity -3.44x); but revenue fell -37.5% YoY.
Revenue (FY2025) $319M · FY2025
Core Scientific, Inc./tx shows $319M in FY2025 revenue (-37.5% YoY), a -90.5% net margin.
Supporting the case: conservative balance sheet (liabilities/equity -3.44x).
Is CORZW a buy? The one-page verdict, explained →
AVOID means we wouldn't engage at all — if expressing the short side anyway, only with capped risk.
Educational template, not a trade recommendation. Strikes and premiums are Black-Scholes model estimates from the last close and 30-day realized volatility — real chains, spreads and IV will differ. Options involve substantial risk.
| Line item | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Revenue | $544M | $640M | $502M | $511M | $319M |
| Gross profit | $239M | $8.40M | $123M | $121M | $37.9M |
| Operating income | $131M | -$2.11B | $8.96M | -$142M | -$246M |
| Net income | $47.3M | -$2.15B | -$246M | -$1.44B | -$289M |
| Diluted EPS | $0.20 | -$6.30 | -$0.65 | -$4.87 | -$0.88 |
| Net margin | 8.7% | -335.2% | -49.1% | -281.6% | -90.5% |
10-year statements — income, cash flow, balance sheet & CSV export →
Annual figures from SEC 10-K XBRL filings. Open the filing links below for full statement detail.
Computed from SEC XBRL annual figures + the current quote. EV and ROIC use long-term + current debt where filed; estimates, not investment advice.
Sources: SEC EDGAR (CIK 0001839341, latest 10-Q filed 2026-05-06) · EODHD · as of 7/4/2026, 11:25:44 PM.
Rule-based analysis, generated automatically from SEC filing data.
Investment recommendation produced by TENK/calls (tenkcalls.com), Luxembourg. Completed Jul 4, 2026, 7:25 PM ET. Ratings & methodology: definitions · All recommendations to date: track record · Conflicts: disclosures. Not investment advice.
Research and education only — not financial advice. TENKis not a registered investment adviser or broker-dealer and gives no personalized advice. Every call is impersonal — identical for all users, generated on a schedule from SEC filings plus a delayed/third-party price feed — may be wrong or out of date, and is not a recommendation to buy or sell any security. The operator and an affiliated trading operation may hold or trade the securities TENK rates; see Disclosures. Past performance does not guarantee future results. Do your own research.
Last 90 days: 0 open-market buys · 13 sales
| 2026-06-30 | Sullivan Adam Taylor Chief Executive Officer | Tax | 18.0K @ $25.59 | $461K |
| 2026-06-30 | DUCHENE TODD M See remarks | Tax | 5.47K @ $25.59 | $140K |
| 2026-06-29 | DUCHENE TODD M See remarks | Sell | 8.80K @ $25.99 | $229K |
| 2026-06-29 | DUCHENE TODD M See remarks | Sell | 1.10K @ $27.42 | $30.2K |
| 2026-06-29 | DUCHENE TODD M See remarks | Sell | 100.00 @ $27.95 | $2.79K |
| 2026-06-22 | DUCHENE TODD M See remarks | Sell | 7.60K @ $29.11 | $221K |
| 2026-06-22 | DUCHENE TODD M See remarks | Sell | 2.40K @ $29.88 | $71.7K |
| 2026-06-15 | DUCHENE TODD M See remarks | Sell | 9.90K @ $28.19 | $279K |
| 2026-06-15 | DUCHENE TODD M See remarks | Sell | 100.00 @ $28.79 | $2.88K |
| 2026-06-08 | DUCHENE TODD M See remarks | Sell | 5.50K @ $26.64 | $147K |
| 2026-06-08 | DUCHENE TODD M See remarks | Sell | 4.50K @ $27.11 | $122K |
| 2026-06-01 | DUCHENE TODD M See remarks | Sell | 1.30K @ $26.93 | $35.0K |
| Point72 Asset Management | 8.48M sh | $74.1M |
| Soros Fund Management | 874K sh | $7.64M |
As of each fund’s latest quarterly 13F — a delayed snapshot, not a live position. All tracked funds →
1195 tracked peers · median